𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutational activation of c-Ha-ras genes in intraductal proliferation induced by N-nitroso-N-methylurea in rat mammary glands

✍ Scribed by Hirotsuka Sakai; Katsuhiro Ogawa


Publisher
John Wiley and Sons
Year
1991
Tongue
French
Weight
665 KB
Volume
49
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Although administration of a single dose of N‐nitroso‐N methylurea (NMU) to young virgin rats induces a high rate of mammary carcinomas, precise histogenesis of the carcinomas has not been well characterized. In this study, we investigated the alterations of H‐ras gene in early focal lesions as well as carcinomas in the mammary glands of F344 rats treated with NMU. At 2 weeks after treatment, intraductal proliferation (IDP) was occasionally observed, and mammary carcinomas emerged at 12 and 36 weeks. The individual lesions of IDP and carcinomas were scooped out from the tissue sections under a stereomicroscope, and the DNA‐sequence‐spanning codon 12 of H‐ras gene was amplified from the tissue sections by polymerase chain reaction (PCR). The analysis of amplified DNA by oligonucleotide hybridization revealed that 65% (11/17) of IDP and 89% (16/18) of carcinomas had a point mutation (G‐to‐A transition) at the 2nd position of H‐ras codon 12. However, the DNA amplified from the areas, which appear histologically normal, never showed such mutation. These results indicate that IDP is a very early change for NMU‐induced mammary carcinogenesis.


📜 SIMILAR VOLUMES


Mutational activation of c-HA-ras gene i
✍ Mami Kudo; Tsutomu Ogura; Hiroyasu Esumi; Takashi Sugimura 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 558 KB

The activation of the c-Ha-ras gene and its carcinogen specificity were examined in squamous cell carcinomas (SCCs) induced by the mutagenic heterocyclic amines 2-amino-3-methylimidazo [4,5-f]quinoline (IQ),2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), and 2-amino-3,4-dimethylimidazo[4,5-f]

Alterations in the Ha-ras-1 and the p53
✍ Katherine E. McKenzie; Barbara A. Armstrong; Ying Chen; Mahalakshmi Nagarajan; C 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 2 views

Well-differentiated mammary carcinomas carrying mutated Ha-ras-1 oncogenes arise frequently in pubescent rats exposed to the direct-acting methylating agent N-methyl-N-nitrosourea (MNU). When these tumors are serially transplanted, they acquire more aggressive phenotypes. To determine the genetic al

G→A mutations in p53 and Ha-ras genes in
✍ Jean-Claude Lozano; Hisayoshi Nakazawa; Marie-Pierre Cros; Ricardo Carbral; Hiro 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 639 KB

## Abstract In human esophageal cancers, no __ras__ gene mutations but a relatively high prevalence of __p53__ gene mutations have been reported. We found a high prevalence of point mutations in Ha‐__ras__ and __p53__ genes in __N__‐nitrosomethylbenzylamine (NMBA)‐induced esophageal tumors in two s

Point mutation in codons 12 and 61 of th
✍ Tsuneo Masui; Angela M. Mann; Emily M. Garland; Takehiko Okamura; Patrik L. Joha 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 651 KB

## Abstract Male F344 rats were fed __N__‐[4‐(5‐nitro‐2‐furyl)‐2‐thiazolyl]formamide (FANFT) for up to 4 wk, then were given the basal diets (Prolab 3200 or AIN‐76A) with or without 5% sodium saccharin for up to 100 wk. Eleven transitional cell carcinomas (TCCs), one undifferentiated carcinoma, and